Key Sessions
William Schaut
Regulatory Requirements for CAR T Starting Materials
Janssen Pharmaceuticals, Inc
James Bolling
Development of a Robust Allogeneic CAR T Manufacturing Process Using the ARCUS® Genome Editing Technology
Precision BioSciences